News-Medical.Net October 17, 2024
Cancer detection in the U.S. significantly disrupted during first year of COVID-19 pandemic, partial recovery seen in second year.
In a recent study published in the JAMA Network Open, a group of researchers assessed the disruption and recovery in cancer detection during the first two years of the coronavirus disease 2019 (COVID-19) pandemic, using national cancer incidence data from 2000 to 2021.
Background
The COVID-19 pandemic significantly disrupted oncologic services, affecting cancer screening, diagnosis, treatment, and survivorship. During the early pandemic, cancer incidence dropped nearly 9% in 2020 and by almost 50% during peak lockdown months due to resource reallocation and patient hesitancy to seek care.
Access to diagnostic cancer services was constrained, and risk tolerance for seeking care...
Today's Sponsors
Today's Sponsor